Your session is about to expire
← Back to Search
Inhaled THC for Cannabis Response Differences by Gender (THC-Gender-II Trial)
THC-Gender-II Trial Summary
This trial looks at how cannabinoids affect men and women differently, and tries to figure out why those differences exist.
THC-Gender-II Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTHC-Gender-II Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.THC-Gender-II Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- You are experiencing a lot of stress right now or have recently experienced a major life event.I am in good physical and mental health.You have used cannabis at least once in your life.People who have never used cannabis before.
- Group 1: Delta-9-Tetrahydrocannabinol (THC)
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the FDA validated Delta-9-Tetrahydrocannabinol (THC) for medicinal use?
"Our team at Power assessed the safety of Delta-9-Tetrahydrocannabinol (THC) to be a 1, as this is a Phase 1 trial with limited evidence in support of its efficacy and security."
Have past experiments utilized Delta-9-Tetrahydrocannabinol (THC) for their research purposes?
"Currently, 6 Phase 3 studies and 38 other active trials exist for Delta-9-Tetrahydrocannabinol (THC). Out of the 90 locations running clinical trials on this substance, a majority are based in Belmont, Massachusetts."
How many participants are currently enrolled in this research program?
"Affirmative. Data on clinicaltrials.gov reveals that the recruitment period for this medical trial is still ongoing, having been first posted in October 2019 and last edited in July 2022. This experiment requires 100 individuals to be recruited from a single site."
Are there currently opportunities to participate in the research trial?
"Yes, the data found on clinicaltrials.gov shows that this medical investigation is presently looking for volunteers. This research effort was launched on October 9th 2019 and last modified July 21st 2022; it seeks 100 participants at a single site."
Are persons below the age of 70 able to join this research experiment?
"This medical research is enrolling individuals that are above the age of consent and not beyond 55 years old."
In what ways is Delta-9-Tetrahydrocannabinol (THC) typically employed therapeutically?
"Delta-9-Tetrahydrocannabinol (THC) is an effective therapeutic for obesity, unresponsiveness to conventional treatments, and pharmacotherapy."
For whom is this clinical investigation available?
"A hundred patients between 18 and 55 that have had prior exposure to cannabis are eligible for this clinical trial. Recruits must be in good physical and psychological health."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger